News In-ear wearable start-up STAT has long COVID in its sights A new US start-up, STAT Health, has emerged from the shadows with $5.1 million in funding to develop an in-ear wearable
Views & Analysis A test of NICE’s resolve: clinical guidelines for Myalgic en... The work of the UK's HTA body, the National Institute for Health and Care Excellence (NICE), is often heatedly debated, and this time it’s for holding back a clinical guideline.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
